The Asacpharma MbM CPI for epidermal regeneration is an advanced dermatological treatment designed to accelerate the recovery of damaged skin. This stimulator acts directly on cellular renewal processes, targeting patients with superficial skin lesions, skin subjected to dermatological procedures, or those with a compromised skin barrier that require rapid structural restoration.
The benefits of MbM CPI are based on its ability to optimize the skin microenvironment, facilitating efficient biological repair. Its technical mechanism of action promotes the proliferation of keratinocytes, resulting in a notable improvement in skin texture and resilience in reduced time.
- Acts as a powerful stimulator of epidermal regeneration, accelerating the closure and healing of damaged epithelial tissues.
- Contributes to the restoration of the skin barrier, increasing the natural protection of the skin against external aggressors and water loss.
- Provides an improvement in elasticity and smoothness of the treated area, minimizing the appearance of imperfections resulting from scarring.
- Supports a more comfortable post-procedure recovery, reducing downtime after intensive dermatological treatments.
- Its technical formula is developed to ensure a high dermal compatibility, allowing its use in sensitive areas with compromised integrity.